-
-
Finance -
Finance -
Pharma & Human Health -
Editor's Choice
Editor’s Choice
Editor's Choice
LACTIN-V: A Promising Live Biotherapeutic for Recurrent Bacterial Vaginosis
Bacterial vaginosis (BV) is one of the most common vaginal conditions affecting women of reproductive age worldwide, with prevalence rates estimated between 15% and 50%. It is a condition characterized by a disruption of the […]
Editor's Choice
Lactic Acid’s Untapped Potential to Optimise the Vaginal Microbiota and Mucosal Environment
Across women’s health, there is growing recognition of the urgent need for antibiotic‑sparing strategies that restore and sustain an optimal vaginal microbiota. Such an ecosystem is typically dominated by Lactobacillus crispatus, a species strongly associated […]
Editor's Choice
Multi-strain probiotic therapy shows promise in preventing bacterial vaginosis recurrence
A global team of experts has identified a promising new approach to prevent recurrence of bacterial vaginosis (BV), a condition that affects millions of women worldwide. In a phase 1 randomized clinical trial of women […]
In Case you Missed it:
Finance
Women’s Health Innovation Is Not Failing – The System Around It Is
Women’s health is not constrained by a lack of scientific progress, but by systems that fail to recognise, prioritise, and translate it. Until those systems evolve, even the most promising innovations will struggle to reach […]
Editor's Choice
Multi-strain probiotic therapy shows promise in preventing bacterial vaginosis recurrence
A global team of experts has identified a promising new approach to prevent recurrence of bacterial vaginosis (BV), a condition that affects millions of women worldwide. In a phase 1 randomized clinical trial of women […]
Pharma & Human Health
Qiagen unveils new high-throughput benchtop automation system
The new QIAsprint Connect is a next generation system for automated high-throughput nucleic acid purification, bringing together walk-away automation, flexible workflows and sustainable design – built for labs that want more control and less manual handling: High-throughput […]
Finance
Opella announces strategic partnership with Verb Biotics for development of next-generation probiotic strain
Opella announces a strategic and exclusive partnership with Verb Biotics for the development of a next-generation probiotic strain and its commercialization. This collaboration merges Opella’s ability to take ideas from concept to execution at global […]
Pharma & Human Health
Cmbio: Advancing Microbiome Innovation Through Digital Biology
Biology is undergoing a structural shift. For decades, progress was driven primarily by experimentation and observation, with each study generating valuable but often isolated insights. Today, multi-omics technologies, automation, large-scale data integration, and AI are […]
Pharma & Human Health
Missing microbes in UK infant gut and probiotics highlighted by global microbiome atlas
A global atlas mapping two key gut bacteria in infants around the world has uncovered a treasure trove of bacterial strains adapted to the infant gut and not found in commercial probiotic products. It lays […]
Pharma & Human Health
How Oral Drugs and Nutrition impacts Microbiome: Realistic Dynamic In Vitro Microbiome Modeling
Not so long ago the gut microbiome was considered a scientific curiosity. Today it’s impossible to ignore. The trillions of microorganisms living in our gastrointestinal tract influence digestion, immunity, metabolism and even mental health. When […]
Pharma & Human Health
Global scientific paper establishes first consensus definition of gut health
Gut health has become a familiar term in both scientific papers and marketing campaigns. Although scientists generally agree that gut health is a key component of overall health and wellness, the concept of gut health […]
